Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
The test is currently being installed in the company’s new state-of-the-art laboratory facility in Salt Lake City, where…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Mar 24
The test is currently being installed in the company’s new state-of-the-art laboratory facility in Salt Lake City, where…
22 Mar 24
The CIARTIC Move system is designed to automate repositioning during surgery, can be moved effortlessly building on its…
22 Mar 24
SimplyPERIO uses a proprietary molecular technology to detect and quantify periodontal bacteria, caries, fungal, and viral targets
22 Mar 24
Naveris is a privately held, commercial stage, precision oncology diagnostics company with facilities in Massachusetts and North Carolina
21 Mar 24
CAD EYE enables real-time detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy procedures and…
18 Mar 24
DermLite develops handheld dermoscopy solutions such as dermatoscopes and phone adapters that use LED lights and magnification lenses…
15 Mar 24
Hartford will upgrade its imaging technology using a phased approach to the acquisition, deployment, and redeployment of essential…
15 Mar 24
Under the partnership, BD and the Poland-based GOCC will expand access to advanced testing for bloodstream infections and…
15 Mar 24
The commercial partnership will integrate Pixyl’s Pixyl.Neuro brain MRI analysis software with Blackford's enterprise AI platform to aid…
14 Mar 24
As per the findings of the research, up to 25% of post-menopausal women at high risk of developing…